DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
The generic ingredient in BREVICON 21-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Profile for product number 001
|Approval Date:||Approved Prior to Jan 1, 1982||TE:||RLD:||No|
Complete Access Available with Subscription